Sun Jian David Sells Shares of 111, Inc.

Sun Jian David sold 58,800 shares of 111, Inc. on June 15, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 2:00 PM EDT

Key Points

Sun Jian David sold 58,800 shares of 111, Inc. on June 15, 2026, valued at $13,524.
111, Inc. has a market cap of $40.2 million, a forward P/E of 32.64, and a beta of 0.609.
Recent insider sales include Sun Jian David and Chen Yang Luke, with multiple transactions in June 2026.

Sun Jian David sold 58,800 shares of 111, Inc. (NasdaqGM: YI) on June 15, 2026. The transaction was valued at $13,524, with each share priced at $0.23.

Insider Buying and Selling at 111, Inc.

Sun Jian David has been actively selling shares of 111, Inc. in June 2026. On June 15, he sold 58,800 shares at $0.23 per share. This follows earlier sales on June 11, where he sold 111,100 shares, and on June 10, where he sold 115,440 shares at $0.22 each. These transactions were not part of a planned trading program. Another insider, Chen Yang Luke, sold 44,000 shares on June 15 and 49,920 shares on June 12, both at $0.23 per share.

Other Institutional Activity in 111, Inc.

Renaissance Technologies LLC increased its holdings by 300 shares, bringing its total to 13,014 shares valued at approximately $84,851. Serenus Wealth Advisors, LLC reduced its position by 64 shares, leaving it with 4,320 shares worth around $321,334. Citigroup Inc acquired 207 shares, resulting in a total holding of 207 shares valued at $1,341. Meanwhile, SBI Securities Co., Ltd. maintained its position with 144 shares valued at $939.

111, Inc. Stock Snapshot

Shares of NasdaqGM:YI recently traded around $4.57. 111, Inc. has a market cap of about $40.2 million and a forward P/E ratio of 32.64. The stock's 52-week range is between $2.48 and $11.17, with a 50-day moving average of $5.88 and a 200-day moving average of $5.40. The company has a current ratio of 1.084 and a quick ratio of 0.366, with a debt-to-equity ratio of 150.925.

About 111, Inc.

111, Inc. operates a platform that integrates online and offline services in the healthcare market in China. The company runs two segments, B2C and B2B, offering supply chain integration, product promotion, and data services. It provides online and offline pharmacies, selling pharmaceuticals, health products, and personal care items. Founded in 2010 and headquartered in Shanghai, the company serves pharmacies, pharmaceutical firms, and healthcare professionals.

Bottom Line

Sun Jian David's recent sales of 111, Inc. shares highlight ongoing insider activity at the company. Investors often track such moves for insights into insider sentiment. It's important to remember that this information is based on past filings and may not reflect current holdings.